🇺🇸 FDA
Patent

US 8632782

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 8632782 (Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/54